Abstract
A small‐scale study funded by the Food and Drug Administration (FDA) found that in community settings (as opposed to ambulances or hospital emergency rooms) where there is no oxygen available, the window in which naloxone can reverse injury due to oxygen deprivation and death due to cardiac arrest is limited. The study, conducted with 21 healthy participants, compared administration of different doses of naloxone, which comes in 4 milligram doses intranasally. The study used simulations of fentanyl administrations. It found that more naloxone has to be given right away, without waiting 2 minutes as is currently recommended before administering the next dose. The study looked at naloxone plasma concentrations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Brown University Child & Adolescent Psychopharmacology Update
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
